Kantonsspital Graubünden, Department of Internal Medicine
Chur, CH 7000, Switzerland
NCT Number: NCT00536068
Nonsteroidal antiinflammatory drugs such as diclofenac or naproxen may interfere with the inhibition of platelet aggregation by aspirin, because they all interact with the platelet cyclooxygenase.This may be of great clinical importance because of an increased cardiovascular event rate (myocardial infarction, stroke). The present randomized, controlled study analyses in vitro platelet aggregation under a combined treatment of healthy volunteers with aspirin and either acetaminophen, diclofenac, naproxen, or placebo.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Chur, CH 7000, Switzerland
An in vivo study on healthy volunteers with combinations of well established drugs
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 days
Kantonsspital Graubünden
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05875272
Cardio-pulmonary Bypass, Extracorporeal Circulation
Amiens, France
View Trial DetailsNCT05323448
Hemostasis, Hemostatics
Bordeaux, France
View Trial DetailsNCT07529106
Extraction Socket Healing, Hemostasis
Coronel Oviedo, Caaguazú Department, Paraguay
View Trial DetailsNCT07354178
Back Injuries, Blood Loss, Surgical
Seoul, Gangnam-gu, South Korea
View Trial Details